Breast cancer is the leading cause of death from cancer in women worldwide, and the
second most common cause of death from cancer in women in the United States. Risk …

While ductal carcinoma in situ (DCIS) is seldom life threatening, the management of DCIS
remains a dilemma for patients and their physicians. Aggressive treatment reduces the risk …

Molecular mechanisms mediating the progression of ductal carcinoma in situ (DCIS) to
invasive breast cancer remain largely unknown. We used gene expression profiling of …

Background Ductal carcinoma in situ (DCIS) is a neoplastic proliferation of epithelial cells
which is confined within the basement membrane of the mammary ductal–lobular system. It …

Ductal carcinoma in situ (DCIS) is a nonobligate precursor to invasive cancer that classically
presents as asymptomatic calcifications on screening mammography. The increase in DCIS …

Over the past decades, luminal epithelial cell lineage has gained considerable attraction as
the functionally milk-secreting units and as the most fruitful acreage for breast cancer …

Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all
solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has …

Purpose Ductal carcinoma in situ (DCIS) is widely recognized as the precursor of invasive
ductal carcinoma (IDC). We aimed to analyze the clinicopathological characteristics and …

Accurate staging of many cancers with no clinical evidence of lymph node involvement is
often a critical component of the management of such cancers and is generally and …

The prevalence of ductal carcinoma in situ (DCIS) of the breast has increased substantially
after the introduction of breast cancer screening programs, although the clinical effects of …